The WorldWide Antimalarial Resistance Network (WWARN) – part of IDDO - is a collaborative research network that is assessing antimalarial drug efficacy by providing policy makers with the evidence needed to plan effective strategies to contain resistance and ensure the most effective use of current and new drugs in the fight to eradicate malaria. A small increase in malaria drug efficacy could have a major impact by stopping millions of cases of recurrent malaria each year.
What does WWARN do?
- Brings together experts from multiple research disciplines, from across the world to assess the evolution, epidemiology and public health impact of drug resistance
- Develops new tools, useful services and valuable training to assure the quality of antimalarial efficacy testing
How does it work?
- We provide the malaria community with a reliable and standardised data collection platform to facilitate data sharing, pooled data analyses, and application of these findings to provide evidence for policy makers and drug developers to optimise the therapeutic life of existing and new antimalarial drugs.
- We collaborate with laboratories across the world to provide support and advice to improve the analysis of antimalarial drug regimens during clinical trials, and in turn, enhancing the overall quality of the research data captured.